{Etokimab: A Deep Investigation into the 2022981-44-6 Protein Etokimab, designated by the specific identifier 2022981-44-6, represents a novel antibody currently in therapeutic evaluation. This biologic agent, https://www.targetmol.com/compound/etokimab